Human African trypanosomiasis.
Lejon V, Lindner AK, Franco JR.
Lancet. 2025 Mar 15;405(10482):937-950. doi: 10.1016/S0140-6736(25)00107-2.
New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine.
Lindner AK, Lejon V, Barrett MP, Blumberg L, Bukachi SA, Chancey RJ, Edielu A, Matemba L, Mesha T, Mwanakasale V, Pasi C, Phiri T, Seixas J, Akl EA, Probyn K, Villanueva G, Simarro PP, Kadima Ebeja A, Franco JR, Priotto G.
Lancet Infect Dis. 2025 Feb;25(2):e77-e85. doi: 10.1016/S1473-3099(24)00581-4. Epub 2024 Oct 7.
Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a prospective, open-label, single-arm, phase 2-3, non-randomised study.
Matovu E, Nyirenda W, Eriatu A, Alves D, Perdrieu C, Lemerani M, Wamboga C, Lejon V, Seixas J, Signorell A, Reymondier A, Baudin E, Scherrer B, Valverde Mordt O.
Lancet Glob Health. 2025 May;13(5):e910-e919. doi: 10.1016/S2214-109X(25)00016-6.
Second stage human African Trypanosomiasis with Trypanosoma brucei rhodesiense treated with fexinidazole.
Helleberg BB, Gudmundsson KSS, Kurtzhals JAL, Helleberg M.
Lancet Infect Dis. 2023 Nov;23(11):e505. doi: 10.1016/S1473-3099(23)00358-4.
Reemergence of Human African Trypanosomiasis Caused by Trypanosoma brucei rhodesiense, Ethiopia.
Abera A, Mamecha T, Abose E, Bokicho B, Ashole A, Bishaw T, Mariyo A, Bogale B, Terefe H, Tadesse H, Belachew M, Difabachew H, Eukubay A, Kinde S, Ali A, Regasa F, Seife F, Kebede Z, Wossen M, Tollera G, Hailu M, Manaye N, Van Reet N, Priotto G, van Griensven J, Pareyn M, Tasew G.
Emerg Infect Dis. 2024 Jan;30(1):125-128. doi: 10.3201/eid3001.231319. Epub 2023 Nov 15.
Human African trypanosomiasis.
Lejon V, Bentivoglio M, Franco JR.
Handb Clin Neurol. 2013;114:169-81. doi: 10.1016/B978-0-444-53490-3.00011-X.
Antitrypanosomal Chloronitrobenzamides.
Carrillo AK, Kadayat TM, Hwang JY, Chen Y, Zhu F, Holbrook G, Gillingwater K, Connelly MC, Yang L, Kaiser M, Guy RK.
J Med Chem. 2024 Mar 14;67(5):3437-3447. doi: 10.1021/acs.jmedchem.3c01680. Epub 2024 Feb 16.
Hybrid-Compounds Against Trypanosomiases.
Nunes JA, Ferreira da Silva-Júnior E.
Curr Drug Targets. 2022;23(14):1319-1329. doi: 10.2174/1389450123666220509202352.
African trypanosomiasis.
Maudlin I.
Ann Trop Med Parasitol. 2006 Dec;100(8):679-701. doi: 10.1179/136485906X112211.
Human African Trypanosomiasis: Progress and Stagnation.
Bottieau E, Clerinx J.
Infect Dis Clin North Am. 2019 Mar;33(1):61-77. doi: 10.1016/j.idc.2018.10.003.
